Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DART Imaging is a Chinese medical imaging company focused on breast cancer screening and diagnosis. The company develops, manufactures, sells, and services digital breast tomosynthesis and digital mammography systems, positioning itself around early detection of breast cancer. Its business is centered on imaging hardware and related screening technology rather than therapeutics, so it does not have a drug pipeline in the biotech sense. DART Imaging appears to be commercially active, with corporate, manufacturing, and service operations in China and recent participation in major medical equipment exhibitions. The company was founded by Dr. Tao Wu, a pioneer in digital breast tomosynthesis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DART Imaging.